| Acronym |
Definition |
| ACCHS |
Aboriginal Community Controlled Health Service |
| AGPS |
Australian Government Publishing Service |
| AHW |
Aboriginal Health Worker |
| AIDS |
acquired immune deficiency syndrome |
| ALT |
alanine transaminase |
| ANCA |
Australian National Council on AIDS |
| ATSI |
Aboriginal and Torres Strait Islander
|
| BBV |
blood-borne virus |
| CARPA |
Central Australian Rural Practitioners’ Association |
| CD4+ T LYMPHOCYTE |
special type of lymphocyte |
| CDCD |
Communicable Disease Control Directorate |
| CIN |
cervical intra-epithelial neoplasia |
| CMW |
cytomegalovirus |
| CO2 |
carbon dioxide |
| CRF |
circulating recombinant form |
| CSF |
cerebrospinal fluid |
| DNA |
deoxyribonucleic acid |
| DOT |
directly observed therapy |
| ECS |
endocervical swab |
| EIA |
enzyme immunoassay |
| ESR |
erythrocyte sedimentation rate |
| FVU |
first void urine |
| FTA-ABS |
fluorescent treponemal antibody absorption test |
| GNID |
Gram-negative intracellular diplococci |
| GUD |
genital ulcer disease |
| HAND |
HIV-associated neurocognitive disorder |
| HAV |
hepatitis A virus |
| HBIG |
hepatitis B immunoglobin |
| HBV |
hepatitis B virus |
| HCV |
hepatitis C virus |
| HIV |
human immunodeficiency virus |
| HPF |
high-powered field |
| HPV |
human papillomavirus |
| HRT |
hormone replacement therapy |
| HSV |
herpes simplex virus |
| IDU |
injecting drug user |
| IGG |
immunoglobulin G |
| IGM |
immunoglobulin M |
| IMI |
intramuscular injection |
| IU |
international unit |
| IUD |
intra-uterine device |
| LCR |
ligase chain reaction |
| LGV |
lymphogranuloma venereum |
| LGV-CFT |
lymphogranuloma venereum complement fixation test |
| MACBBVS |
Ministerial Advisory Committee on Blood Borne Viruses and Sexually Transmissible Infections |
| MC&S |
microscopy, culture and sensitivity testing |
| MSM |
men who have sex with men |
| N2O |
nitrous oxide |
| NAAT |
nucleic acid amplification test |
| NGU |
non-gonococcal urethritis |
| NHIG |
normal human immunoglobulin |
| NHMRC |
National Health and Medical Research Council |
| NPEP |
non-occupational post-exposure prophylaxis |
| NSU |
non-specific urethritis |
| PAP SMEAR |
Papanicolaou smear |
| PBS |
Pharmaceutical Benefits Scheme |
| PCR |
polymerase chain reaction |
| PEP |
post-exposure prophylaxis |
| PHU |
population/public health unit |
| PID |
pelvic inflammatory disease |
| RNA |
ribonucleic acid |
| RPR |
rapid plasma reagin test |
| SARC |
Sexual Assault Resource Centre |
| SOLVS |
self-obtained low vaginal swab |
| SOPV |
sex-on-premises venue |
| STD |
sexually transmitted disease |
| STI |
sexually transmitted infection |
| TPHA |
Treponema pallidum haemagglutination test |
| TPPA |
Treponema pallidum particle agglutination test |
| UTI |
urinary tract infection |
| VDRL |
Venereal Disease Research Laboratory test |
| WA |
Western Australia |
| WA HEALTH |
Western Australian Department of Health |
| WANIDD |
Western Australian Notifiable Infectious Diseases Database |
| WBC |
white blood cells |
| WHO |
World Health Organization |